Hangzhou Alltest Biotech Co., Ltd. Stock
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
66.73 CNY | -1.17% | +0.35% | -2.73% |
Apr. 29 | China, HK stocks rise, led by property shares | RE |
Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 3.39B 469M | Sales 2023 | 755M 104M | Capitalization | 5.36B 742M |
---|---|---|---|---|---|
Net income 2022 | 1.18B 164M | Net income 2023 | 181M 25.06M | EV / Sales 2022 | 0.51 x |
Net cash position 2022 | 3.79B 525M | Net cash position 2023 | 2.76B 383M | EV / Sales 2023 | 3.44 x |
P/E ratio 2022 |
4.75
x | P/E ratio 2023 |
30.1
x | Employees | 1,244 |
Yield 2022 |
9.58% | Yield 2023 |
-
| Free-Float | 33.28% |
1 day | -1.17% | ||
1 week | +0.35% | ||
Current month | +0.35% | ||
1 month | -2.46% | ||
3 months | +11.40% | ||
6 months | -10.31% | ||
Current year | -2.73% |
Managers | Title | Age | Since |
---|---|---|---|
Fei Gao
CEO | Chief Executive Officer | 50 | 14-06-30 |
Yan Ping Fu
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Wei Ke Lu
COO | Chief Operating Officer | 43 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fei Gao
CEO | Chief Executive Officer | 50 | 14-06-30 |
Hua Fang Zhao
BRD | Director/Board Member | 50 | 14-09-30 |
Wei Ke Lu
COO | Chief Operating Officer | 43 | 14-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 66.73 | -1.17% | 587,636 |
24-05-08 | 67.52 | +0.06% | 283,195 |
24-05-07 | 67.48 | -1.58% | 512,837 |
24-05-06 | 68.56 | +3.10% | 1,005,625 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-2.73% | 716M | |
-1.34% | 12.64B | |
-1.64% | 8.37B | |
+0.09% | 5.37B | |
+22.42% | 5.26B | |
-0.09% | 4.58B | |
-52.84% | 3.16B | |
+20.02% | 2.89B | |
+31.92% | 2.29B | |
-2.45% | 1.91B |
- Stock Market
- Equities
- 688606 Stock